In April 2010, sipuleucel-T (Provenge; Dendreon), an autologous cellular immunotherapy, was approved by the US FDA for the treatment of asymptomatic or minimally symptomatic metastatic castration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback